Glaucoma Research Foundation Earns Highest Rating from Charity Navigator for Fourth Consecutive Year
The 4-star rating is Charity Navigator's highest possible rating and indicates that Glaucoma Research Foundation adheres to sector best practices and executes its mission in a financially efficient way.
1-Jun-2020 7:35 PM EDT Add to Favorites
The glaucoma specialist and researcher from Glaucoma Center of San Francisco is also a medical editor for the Gleams newsletter published by Glaucoma Research Foundation and lecturer at the annual Glaucoma 360 Symposium in San Francisco.
27-Apr-2020 8:45 AM EDT Add to Favorites
The annual Glaucoma 360 Gala at the Grand Hyatt San Francisco honored leaders in glaucoma research innovation and visionary glaucoma advocates helping to raise awareness.
17-Mar-2020 5:40 PM EDT Add to Favorites
Glaucoma Research Foundation Announces $1.2 Million in Annual Research Grants during World Glaucoma Week
GRF annual glaucoma research grants will support 12 investigators at prestigious colleges and universities across the United States.
10-Mar-2020 12:45 PM EDT Add to Favorites
The Shaffer Prize recognizes a researcher whose project best exemplifies the pursuit of innovative ideas in the quest to better understand and cure glaucoma.
5-Mar-2020 5:05 PM EST Add to Favorites
The three-day event highlights innovation in glaucoma therapies to ensure patients have access to the latest and most effective diagnostic tools and treatment options.
2-Jan-2020 4:55 PM EST Add to Favorites
Glaucoma Research Foundation to Honor Leaders in Glaucoma Innovation at 2020 Annual Gala in San Francisco
Ophthalmology industry innovators Vicente Anido, Jr., PhD and Thomas A. Mitro of Aerie Pharmaceuticals, Inc. will be honored at the Glaucoma 360 Annual Gala on February 6, 2020 in San Francisco.
11-Dec-2019 7:05 AM EST Add to Favorites
Preliminary applications for one-year Shaffer Grants in the amount of $50,000 are being accepted until July 15, 2019 through the Glaucoma Research Foundation website.
18-Jun-2019 2:05 PM EDT Add to Favorites
See All News
At present, the only FDA approved method of treating glaucoma is to lower eye pressure; this slows the progression of glaucomatous optic nerve damage but does not completely halt it, and certainly does not regenerate damaged nerve tissue.
16-Jun-2017 11:45 AM EDT
Stem cells may have the potential to protect the optic nerve from further damage and slow the progression of vision loss due to glaucoma. Stem cells may also have the potential to replace ocular tissues that have degenerated in eyes with glaucoma.
17-Mar-2016 9:05 AM EDT